This call focuses on biotherapies and bioproduction, which falls outside Acme Corporation's core domains of semiconductors, AI, and deep tech. While France is a target region, the life sciences / biotechnology sector is fundamentally misaligned with the client's stated strategic priorities in semiconductors, photonics, and space/defence.
L’appel à projets « Innovations en biothérapies et bioproduction » est un dispositif d’aide s’inscrivant dans le cadre de la stratégie d’accélération ...